Pages that link to "Q41604126"
Jump to navigation
Jump to search
The following pages link to Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature (Q41604126):
Displaying 34 items.
- Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources (Q28250490) (← links)
- Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study (Q34571228) (← links)
- The continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice (Q34703735) (← links)
- Assessment of the consistency among three drug compendia in listing and ranking of drug-drug interactions (Q35100012) (← links)
- Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation. (Q35135985) (← links)
- e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers (Q35640420) (← links)
- Physicians' reported needs of drug information at point of care in Sweden (Q35640474) (← links)
- Comparative assessment of four drug interaction compendia (Q36024425) (← links)
- Clinical pharmacology information in summaries of product characteristics and package inserts. (Q36780756) (← links)
- Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments (Q36785642) (← links)
- Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot) (Q37133932) (← links)
- Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugs (Q37156285) (← links)
- Development of a standardized knowledge base to generate individualized medication plans automatically with drug administration recommendations (Q37193978) (← links)
- Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment (Q37440590) (← links)
- Predicting the clinical relevance of drug interactions from pre-approval studies. (Q37610142) (← links)
- Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics (Q38848409) (← links)
- Definition of variables required for comprehensive description of drug dosage and clinical pharmacokinetics (Q38961296) (← links)
- Quantifying the amount of information available in order to prescribe, dispense and administer drugs (Q42545821) (← links)
- Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care (Q43797117) (← links)
- Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment. (Q44670585) (← links)
- Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study. (Q45066036) (← links)
- Inconsistencies and misleading information in officially approved prescribing information from three major drug markets (Q46177067) (← links)
- An evaluation of the completeness of drug-drug interaction-related information in package inserts. (Q48263181) (← links)
- Electronic decision support to promote medication safety (Q50014385) (← links)
- Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial. (Q51767440) (← links)
- Advice on drug safety in pregnancy: are there differences between commonly used sources of information? (Q53210241) (← links)
- SFINX—a drug-drug interaction database designed for clinical decision support systems (Q56828588) (← links)
- Patientensicherheit durch computerbasierte Arzneimittelinformationen (Q56832617) (← links)
- Different indications, warnings and precautions, and contraindications for the same drug-an international comparison of prescribing information for commonly used psychiatric drugs (Q57779934) (← links)
- Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials (Q59136927) (← links)
- Critical issues associated with drug–drug interactions: Highlights of a multistakeholder conference (Q84047213) (← links)
- An inventory of medicinal products causing skin rash: Clinical and regulatory lessons (Q91671707) (← links)
- Drug information centre queries and responses about drug interactions over 10 years-A descriptive analysis (Q91924155) (← links)
- Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Community Pharmacy Setting (Q95853112) (← links)